Linghui Lu

Beijing, 100029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Target-centered network pharmacology and molecular docking reveal potential mechanisms and bioactive compounds of Zhigancao Decoction in insomnia-Arrhythmia comorbidity.

Target-centered network pharmacology and molecular docking reveal potential mechanisms and bioactive compounds of Zhigancao Decoction in insomnia-Arrhythmia comorbidity.

Journal: Medicine

Published: May 05, 2026

Qishen Granule protects against myocardial ischemia by promoting angiogenesis through BMP2-Dll4-Notch1 pathway.

Qishen Granule protects against myocardial ischemia by promoting angiogenesis through BMP2-Dll4-Notch1 pathway.

Journal: Chinese herbal medicines

Published: July 22, 2023

Qishen granules regulate intestinal microecology to improve cardiac function in rats with heart failure.

Qishen granules regulate intestinal microecology to improve cardiac function in rats with heart failure.

Journal: Frontiers in microbiology

Published: April 09, 2023

Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.

Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.

Journal: Journal of ethnopharmacology

Published: January 28, 2023

Exploring the Mechanism of Si-miao-yong-an Decoction in the Treatment of Coronary Heart Disease based on Network Pharmacology and Experimental Verification.

Exploring the Mechanism of Si-miao-yong-an Decoction in the Treatment of Coronary Heart Disease based on Network Pharmacology and Experimental Verification.

Journal: Combinatorial chemistry & high throughput screening

Published: October 24, 2022

Evaluation of the transverse aortic constriction model in ICR and C57BL/6J mice.

Evaluation of the transverse aortic constriction model in ICR and C57BL/6J mice.

Journal: Frontiers in physiology

Published: August 24, 2022

Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.

Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 20, 2022

The roles of the mitophagy inducer Danqi pill in heart failure: A new therapeutic target to preserve energy metabolism.

The roles of the mitophagy inducer Danqi pill in heart failure: A new therapeutic target to preserve energy metabolism.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 14, 2021

Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis.

Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis.

Journal: Frontiers in pharmacology

Published: December 02, 2021

Mechanistic Insights of Qingre Jiedu Recipe Based on Network Pharmacology Approach against Heart Failure.

Mechanistic Insights of Qingre Jiedu Recipe Based on Network Pharmacology Approach against Heart Failure.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: September 16, 2021

β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure.

β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure.

Journal: European journal of pharmacology

Published: May 25, 2021

TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy.

TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy.

Journal: International journal of molecular sciences

Published: April 30, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026